NVCR

insider transactions

NovoCure Ltd — buys & sells by directors, officers and 10% owners (SEC Form 4).

30D 90D 1Y

Net shares · 365d

-156.3K

0 buy · 156.3K sell

Net value · 365d

-$2.3M

$0 in · $2.3M out

Sentiment · 365d

Net selling

0% buying · 100% selling

Open-market trades · 365d

0 buy · 156.3K sell

Net buy / sell volume

Tap or hover the chart for daily net volume. Green = net buying, red = net selling.

All transactions

Grant·A
Jun 16, 26

Jeryl L Hilleman

Director

$0

10.9K sh

Own +76%
Sell·S
Jun 4, 26

Frank X Leonard KEY

Chief Executive Officer

$614.6K

34.3K sh · $17.93

Own -7%
Grant·A
Jun 4, 26

Jeryl L Hilleman

Director

$0

11.0K sh

Own +33%
Grant·A
Jun 3, 26

Kristin Stafford

Director

$0

17.0K sh

Own New
Grant·A
Jun 3, 26

Kristin Stafford

Director

$0

11.6K sh

Own +103%
Grant·A
Jun 3, 26

Allyson J Ocean

Director

$0

17.0K sh

Own New
Grant·A
Jun 3, 26

Allyson J Ocean

Director

$0

11.6K sh

Own +103%
Grant·A
Jun 3, 26

Timothy J Scannell

Director

$0

17.0K sh

Own New
Grant·A
Jun 3, 26

Timothy J Scannell

Director

$0

11.6K sh

Own +81%
Grant·A
Jun 3, 26

Anthony W Vernon

Director

$0

17.0K sh

Own New
Grant·A
Jun 3, 26

Anthony W Vernon

Director

$0

11.6K sh

Own +6%
Grant·A
Jun 3, 26

Martin J. Madden

Director

$0

17.0K sh

Own New
Grant·A
Jun 3, 26

Martin J. Madden

Director

$0

11.6K sh

Own +62%
Grant·A
Jun 3, 26

Gabriel Leung

Director

$0

17.0K sh

Own New
Grant·A
Jun 3, 26

Gabriel Leung

Director

$0

11.6K sh

Own +13%
Grant·A
Jun 3, 26

David Hung

Director

$0

17.0K sh

Own New
Grant·A
Jun 3, 26

David Hung

Director

$0

11.6K sh

Own +57%
Grant·A
Jun 3, 26

Jeryl L Hilleman

Director

$0

17.0K sh

Own New
Grant·A
Jun 3, 26

Jeryl L Hilleman

Director

$0

11.6K sh

Own +84%
Sell·S
Jun 2, 26

Kristin Stafford

Director

$46.4K

2.9K sh · $15.77

Own -21%
Sell·S
Jun 2, 26

Allyson J Ocean

Director

$46.4K

2.9K sh · $15.77

Own -21%
Sell·S
Jun 2, 26

Timothy J Scannell

Director

$46.4K

2.9K sh · $15.77

Own -17%
Sell·S
Jun 2, 26

Anthony W Vernon

Director

$46.4K

2.9K sh · $15.77

Own -1%
Sell·S
Jun 2, 26

Gabriel Leung

Director

$46.4K

2.9K sh · $15.77

Own -3%
Sell·S
Jun 2, 26

David Hung

Director

$46.4K

2.9K sh · $15.77

Own -13%
Sell·S
Jun 2, 26

Jeryl L Hilleman

Director

$46.4K

2.9K sh · $15.77

Own -18%
Exercise·M
Apr 28, 26

Anthony W Vernon

Director

$0

21.5K sh

Own New
Exercise·M
Apr 28, 26

Anthony W Vernon

Director

$244.9K

21.5K sh · $11.39

Own +12%
Grant·A
Apr 5, 26

Jeryl L Hilleman

Director

$0

1.5K sh

Own +12%
Grant·A
Apr 1, 26

Martin J. Madden

Director

$0

10.0K sh

Own New
Sell·S
Mar 5, 26

Mukund Paravasthu

Chief Operating Officer

$595.7K

43.2K sh · $13.77

Own -37%
Sell·S
Mar 4, 26

Mukund Paravasthu

Chief Operating Officer

$71.5K

5.4K sh · $13.31

Own -4%
Sell·S
Mar 4, 26

Michal Nath Puri

Chief Human Resources Officer

$14.6K

1.1K sh · $13.31

Own -1%
Sell·S
Mar 4, 26

Uri Weinberg

Chf Medical and Innovation Ofr

$85.3K

6.4K sh · $13.31

Own -2%
Sell·S
Mar 4, 26

Nicolas Leupin

Former Chief Medical Officer

$14.6K

1.1K sh · $13.31

Own -1%
Sell·S
Mar 4, 26

Frank X Leonard KEY

Chief Executive Officer

$74.6K

5.6K sh · $13.31

Own -1%
Other·F
Mar 4, 26

Ashley Cordova KEY

Former Chief Executive Officer

$234.6K

17.6K sh · $13.30

Own -4%
Sell·S
Mar 4, 26

Christoph Brackmann KEY

Chief Financial Officer

$85.3K

6.4K sh · $13.31

Own -3%
Grant·A
Mar 3, 26

Mukund Paravasthu

Chief Operating Officer

$0

58.5K sh

Own +778%
Grant·A
Mar 3, 26

Mukund Paravasthu

Chief Operating Officer

$0

7.5K sh

Own New
Grant·A
Mar 3, 26

Mukund Paravasthu

Chief Operating Officer

$0

45.1K sh

Own +59%
Grant·A
Mar 3, 26

Michal Nath Puri

Chief Human Resources Officer

$0

58.7K sh

Own New
Grant·A
Mar 3, 26

Michal Nath Puri

Chief Human Resources Officer

$0

40.1K sh

Own +25%
Grant·A
Mar 3, 26

Uri Weinberg

Chf Medical and Innovation Ofr

$0

73.3K sh

Own New
Grant·A
Mar 3, 26

Uri Weinberg

Chf Medical and Innovation Ofr

$0

50.1K sh

Own +22%
Grant·A
Mar 3, 26

Frank X Leonard KEY

Chief Executive Officer

$0

216.4K sh

Own New
Grant·A
Mar 3, 26

Frank X Leonard KEY

Chief Executive Officer

$0

150.0K sh

Own +43%
Grant·A
Mar 3, 26

Christoph Brackmann KEY

Chief Financial Officer

$0

80.7K sh

Own New
Grant·A
Mar 3, 26

Christoph Brackmann KEY

Chief Financial Officer

$0

55.1K sh

Own +41%
Grant·A
Mar 3, 26

Arye Barak Ben

General Counsel

$0

73.3K sh

Own New
Grant·A
Mar 3, 26

Arye Barak Ben

General Counsel

$0

50.1K sh

Own +26%
Sell·S
Mar 2, 26

Mukund Paravasthu

Chief Operating Officer

$5.5K

408 sh · $13.49

Own -1%
Sell·S
Mar 2, 26

Uri Weinberg

Chf Medical and Innovation Ofr

$43.6K

3.3K sh · $13.33

Own -1%
Sell·S
Mar 2, 26

Frank X Leonard KEY

Chief Executive Officer

$97.6K

7.2K sh · $13.49

Own -2%
Other·F
Mar 2, 26

Ashley Cordova KEY

Former Chief Executive Officer

$98.8K

7.2K sh · $13.67

Own -2%
Other·F
Mar 2, 26

Ashley Cordova KEY

Former Chief Executive Officer

$32.9K

2.4K sh · $13.67

Own -1%
Grant·A
Feb 28, 26

Uri Weinberg

Chf Medical and Innovation Ofr

$0

13.0K sh

Own +6%
Grant·A
Feb 28, 26

Frank X Leonard KEY

Chief Executive Officer

$0

18.6K sh

Own +6%
Grant·A
Feb 28, 26

Ashley Cordova KEY

Former Chief Executive Officer

$0

23.8K sh

Own +6%
Grant·A
Feb 28, 26

Arye Barak Ben

General Counsel

$0

17.8K sh

Own +10%
Sell·S
Feb 27, 26

Mukund Paravasthu

Chief Operating Officer

$21.2K

1.6K sh · $13.66

Own -2%
Sell·S
Feb 27, 26

Michal Nath Puri

Chief Human Resources Officer

$19.7K

1.4K sh · $13.66

Own -1%
Sell·S
Feb 27, 26

Uri Weinberg

Chf Medical and Innovation Ofr

$103.3K

7.5K sh · $13.84

Own -3%
Sell·S
Feb 27, 26

Nicolas Leupin

Former Chief Medical Officer

$14.1K

1.0K sh · $13.66

Own -1%
Sell·S
Feb 27, 26

Frank X Leonard KEY

Chief Executive Officer

$133.0K

9.7K sh · $13.66

Own -3%
Grant·A
Feb 27, 26

David Hung KEY

PRESIDENT AND CEO

$0

2.0M sh

Own New
Other·F
Feb 27, 26

Ashley Cordova KEY

Former Chief Executive Officer

$158.7K

11.5K sh · $13.75

Own -3%
Other·F
Jan 11, 26

Mukund Paravasthu

Chief Operating Officer

$30.6K

2.1K sh · $14.35

Own -3%
Grant·A
Jan 5, 26

Jeryl L Hilleman

Director

$0

1.6K sh

Own +14%

Date▾	Insider	Role	Type	Shares	Own Δ	Price	Value
Jun 16, 2026	Jeryl L Hilleman	Director	Grant A	10.9K	+76%	—	$0
Jun 4, 2026	Frank X Leonard KEY	Chief Executive Officer	Sell S	34.3K	-7%	$17.93	$614.6K
Jun 4, 2026	Jeryl L Hilleman	Director	Grant A	11.0K	+33%	—	$0
Jun 3, 2026	Kristin Stafford	Director	Grant A	17.0K	New	—	$0
Jun 3, 2026	Kristin Stafford	Director	Grant A	11.6K	+103%	—	$0
Jun 3, 2026	Allyson J Ocean	Director	Grant A	17.0K	New	—	$0
Jun 3, 2026	Allyson J Ocean	Director	Grant A	11.6K	+103%	—	$0
Jun 3, 2026	Timothy J Scannell	Director	Grant A	17.0K	New	—	$0
Jun 3, 2026	Timothy J Scannell	Director	Grant A	11.6K	+81%	—	$0
Jun 3, 2026	Anthony W Vernon	Director	Grant A	17.0K	New	—	$0
Jun 3, 2026	Anthony W Vernon	Director	Grant A	11.6K	+6%	—	$0
Jun 3, 2026	Martin J. Madden	Director	Grant A	17.0K	New	—	$0
Jun 3, 2026	Martin J. Madden	Director	Grant A	11.6K	+62%	—	$0
Jun 3, 2026	Gabriel Leung	Director	Grant A	17.0K	New	—	$0
Jun 3, 2026	Gabriel Leung	Director	Grant A	11.6K	+13%	—	$0
Jun 3, 2026	David Hung	Director	Grant A	17.0K	New	—	$0
Jun 3, 2026	David Hung	Director	Grant A	11.6K	+57%	—	$0
Jun 3, 2026	Jeryl L Hilleman	Director	Grant A	17.0K	New	—	$0
Jun 3, 2026	Jeryl L Hilleman	Director	Grant A	11.6K	+84%	—	$0
Jun 2, 2026	Kristin Stafford	Director	Sell S	2.9K	-21%	$15.77	$46.4K
Jun 2, 2026	Allyson J Ocean	Director	Sell S	2.9K	-21%	$15.77	$46.4K
Jun 2, 2026	Timothy J Scannell	Director	Sell S	2.9K	-17%	$15.77	$46.4K
Jun 2, 2026	Anthony W Vernon	Director	Sell S	2.9K	-1%	$15.77	$46.4K
Jun 2, 2026	Gabriel Leung	Director	Sell S	2.9K	-3%	$15.77	$46.4K
Jun 2, 2026	David Hung	Director	Sell S	2.9K	-13%	$15.77	$46.4K
Jun 2, 2026	Jeryl L Hilleman	Director	Sell S	2.9K	-18%	$15.77	$46.4K
Apr 28, 2026	Anthony W Vernon	Director	Exercise M	21.5K	New	—	$0
Apr 28, 2026	Anthony W Vernon	Director	Exercise M	21.5K	+12%	$11.39	$244.9K
Apr 5, 2026	Jeryl L Hilleman	Director	Grant A	1.5K	+12%	—	$0
Apr 1, 2026	Martin J. Madden	Director	Grant A	10.0K	New	—	$0
Mar 5, 2026	Mukund Paravasthu	Chief Operating Officer	Sell S	43.2K	-37%	$13.77	$595.7K
Mar 4, 2026	Mukund Paravasthu	Chief Operating Officer	Sell S	5.4K	-4%	$13.31	$71.5K
Mar 4, 2026	Michal Nath Puri	Chief Human Resources Officer	Sell S	1.1K	-1%	$13.31	$14.6K
Mar 4, 2026	Uri Weinberg	Chf Medical and Innovation Ofr	Sell S	6.4K	-2%	$13.31	$85.3K
Mar 4, 2026	Nicolas Leupin	Former Chief Medical Officer	Sell S	1.1K	-1%	$13.31	$14.6K
Mar 4, 2026	Frank X Leonard KEY	Chief Executive Officer	Sell S	5.6K	-1%	$13.31	$74.6K
Mar 4, 2026	Ashley Cordova KEY	Former Chief Executive Officer	Other F	17.6K	-4%	$13.30	$234.6K
Mar 4, 2026	Christoph Brackmann KEY	Chief Financial Officer	Sell S	6.4K	-3%	$13.31	$85.3K
Mar 3, 2026	Mukund Paravasthu	Chief Operating Officer	Grant A	58.5K	+778%	—	$0
Mar 3, 2026	Mukund Paravasthu	Chief Operating Officer	Grant A	7.5K	New	—	$0
Mar 3, 2026	Mukund Paravasthu	Chief Operating Officer	Grant A	45.1K	+59%	—	$0
Mar 3, 2026	Michal Nath Puri	Chief Human Resources Officer	Grant A	58.7K	New	—	$0
Mar 3, 2026	Michal Nath Puri	Chief Human Resources Officer	Grant A	40.1K	+25%	—	$0
Mar 3, 2026	Uri Weinberg	Chf Medical and Innovation Ofr	Grant A	73.3K	New	—	$0
Mar 3, 2026	Uri Weinberg	Chf Medical and Innovation Ofr	Grant A	50.1K	+22%	—	$0
Mar 3, 2026	Frank X Leonard KEY	Chief Executive Officer	Grant A	216.4K	New	—	$0
Mar 3, 2026	Frank X Leonard KEY	Chief Executive Officer	Grant A	150.0K	+43%	—	$0
Mar 3, 2026	Christoph Brackmann KEY	Chief Financial Officer	Grant A	80.7K	New	—	$0
Mar 3, 2026	Christoph Brackmann KEY	Chief Financial Officer	Grant A	55.1K	+41%	—	$0
Mar 3, 2026	Arye Barak Ben	General Counsel	Grant A	73.3K	New	—	$0
Mar 3, 2026	Arye Barak Ben	General Counsel	Grant A	50.1K	+26%	—	$0
Mar 2, 2026	Mukund Paravasthu	Chief Operating Officer	Sell S	408	-1%	$13.49	$5.5K
Mar 2, 2026	Uri Weinberg	Chf Medical and Innovation Ofr	Sell S	3.3K	-1%	$13.33	$43.6K
Mar 2, 2026	Frank X Leonard KEY	Chief Executive Officer	Sell S	7.2K	-2%	$13.49	$97.6K
Mar 2, 2026	Ashley Cordova KEY	Former Chief Executive Officer	Other F	7.2K	-2%	$13.67	$98.8K
Mar 2, 2026	Ashley Cordova KEY	Former Chief Executive Officer	Other F	2.4K	-1%	$13.67	$32.9K
Feb 28, 2026	Uri Weinberg	Chf Medical and Innovation Ofr	Grant A	13.0K	+6%	—	$0
Feb 28, 2026	Frank X Leonard KEY	Chief Executive Officer	Grant A	18.6K	+6%	—	$0
Feb 28, 2026	Ashley Cordova KEY	Former Chief Executive Officer	Grant A	23.8K	+6%	—	$0
Feb 28, 2026	Arye Barak Ben	General Counsel	Grant A	17.8K	+10%	—	$0
Feb 27, 2026	Mukund Paravasthu	Chief Operating Officer	Sell S	1.6K	-2%	$13.66	$21.2K
Feb 27, 2026	Michal Nath Puri	Chief Human Resources Officer	Sell S	1.4K	-1%	$13.66	$19.7K
Feb 27, 2026	Uri Weinberg	Chf Medical and Innovation Ofr	Sell S	7.5K	-3%	$13.84	$103.3K
Feb 27, 2026	Nicolas Leupin	Former Chief Medical Officer	Sell S	1.0K	-1%	$13.66	$14.1K
Feb 27, 2026	Frank X Leonard KEY	Chief Executive Officer	Sell S	9.7K	-3%	$13.66	$133.0K
Feb 27, 2026	David Hung KEY	PRESIDENT AND CEO	Grant A	2.0M	New	—	$0
Feb 27, 2026	Ashley Cordova KEY	Former Chief Executive Officer	Other F	11.5K	-3%	$13.75	$158.7K
Jan 11, 2026	Mukund Paravasthu	Chief Operating Officer	Other F	2.1K	-3%	$14.35	$30.6K
Jan 5, 2026	Jeryl L Hilleman	Director	Grant A	1.6K	+14%	—	$0

About NVCR insider trading

This page tracks insider transactions for NovoCure Ltd (NVCR) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.